Lumos Diagnostics Holdings Limited (ASX:LDX)
0.0280
+0.0020 (7.69%)
May 14, 2025, 4:10 PM AEST
ASX:LDX Revenue
Lumos Diagnostics Holdings had revenue of $6.31M USD in the half year ending December 31, 2024, with 23.96% growth. This brings the company's revenue in the last twelve months to $14.67M, up 78.61% year-over-year. In the fiscal year ending June 30, 2024, Lumos Diagnostics Holdings had annual revenue of $11.13M with 5.66% growth.
Revenue (ttm)
$14.67M
Revenue Growth
+78.61%
P/S Ratio
0.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
19.46M AUD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Regis Healthcare | 1.10B |